Literature DB >> 30351201

An Age-Specific Serum Thyrotropin Reference Range for the Diagnosis of Thyroid Diseases in Older Adults: A Cross-Sectional Survey in China.

Xiaodan Zhai1, Le Zhang1, Lulu Chen2, Xiaolan Lian3, Chao Liu4, Bingyin Shi5, Lixin Shi6, Nanwei Tong7, Shu Wang8, Jianping Weng9, Jiajun Zhao10, Xiaochun Teng11, Xiaohui Yu11, Yaxin Lai11, Weiwei Wang11, Chenyan Li11, Jinyuan Mao11, Yongze Li11, Chenling Fan11, Ling Li1, Zhongyan Shan11, Weiping Teng11.   

Abstract

Background: The fact that serum thyrotropin (TSH) levels increase with age may influence the diagnosis of thyroid diseases in older adults. This study aimed to establish an age-specific serum TSH reference range, examine the prevalence of thyroid diseases in older adults ≥65 years, and analyze the risk factors.
Methods: A cross-sectional study of adult populations in 10 cities in China was conducted from 2010 to 2011. A total of 15,008 subjects were randomly selected and completed the present study. Urinary iodine concentration, serum TSH, thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TgAb) titers were measured. Thyroid ultrasonography and questionnaires were completed by all the subjects. When the TSH level was abnormal, free thyroxine and/or free triiodothyronine levels were measured.
Results: When the reference range of the general population was used, the prevalence rates of overt hypothyroidism (Ohypo) and subclinical hypothyroidism (Shypo) in older adults ≥65 years were significantly higher than those in younger adults <65 years (2.09% vs. 0.80% and 19.87% vs. 16.23%, respectively; p < 0.001). Positive TPOAb and positive TgAb were associated with the prevalence of Shypo in older adults. An age-specific serum TSH reference range was formulated according to guidelines set forth by the National Academy of Clinical Biochemistry. Both the median and upper limit values of serum TSH in older adults were higher than those in younger adults (2.58 [0.75-8.86] mIU/L vs. 2.38 [0.76-6.57] mIU/L; p < 0.001). Using the age-specific serum TSH reference range, the prevalence of Shypo in older adults was 3.3%, which was significantly lower than the prevalence based on the reference range of the general population (3.3% vs. 19.87%). The prevalence rates of Ohypo, overt hyperthyroidism (Ohyper), and subclinical hyperthyroidism (Shyper) did not change much (Ohypo: 1.6% vs. 2.09%; Ohyper: 0.7% vs. 0.52%; and Shyper: 3.8% vs. 0.73%). Positive TPOAb, but not positive TgAb, was also associated with the prevalence of Shypo as diagnosed with the age-specific serum TSH reference range.
Conclusion: The serum TSH level increases with age, which may represent a normal compensatory phenomenon in older adults ≥65 years. To prevent misdiagnosis and mistreatment, the use of an age-specific serum TSH reference range is recommended in older adults for the diagnosis of thyroid diseases.

Entities:  

Keywords:  China; TSH; older adults; reference range; thyroid diseases

Mesh:

Substances:

Year:  2018        PMID: 30351201     DOI: 10.1089/thy.2017.0715

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  15 in total

Review 1.  Diagnosis and treatment of hypothyroidism in the elderly.

Authors:  Leonidas H Duntas; Paul Michael Yen
Journal:  Endocrine       Date:  2019-09-03       Impact factor: 3.633

2.  Iodine in household cooking salt no longer plays a crucial role in iodine status of residents in Tianjin, China.

Authors:  Yushan Cui; Yang Wang; Changchun Hou; Dandan Zhang; Pai Zheng; Zhangjian Chen; Wenfeng Li; Yani Duan; Fang Li; Hongliang Liu; Guang Jia
Journal:  Eur J Nutr       Date:  2022-02-09       Impact factor: 4.865

3.  Climate and air pollution exposure are associated with thyroid function parameters: a retrospective cross-sectional study.

Authors:  Y Zeng; H He; X Wang; M Zhang; Z An
Journal:  J Endocrinol Invest       Date:  2020-11-07       Impact factor: 4.256

4.  Association between different obesity phenotypes and hypothyroidism: a study based on a longitudinal health management cohort.

Authors:  Yupeng Wang; Haiyan Lin; Qihang Li; Liying Guan; Meng Zhao; Fang Zhong; Jing Liu; Zhongshang Yuan; Honglin Guo; Yongfeng Song; Ling Gao; Jiajun Zhao
Journal:  Endocrine       Date:  2021-04-05       Impact factor: 3.633

5.  Moderating Role of TSHR and PTPN22 Gene Polymorphisms in Effects of Excessive Fluoride on Thyroid: a School-Based Cross-Sectional Study.

Authors:  Yang Wang; Yushan Cui; Dandan Zhang; Chen Chen; Changchun Hou; Lichun Cao
Journal:  Biol Trace Elem Res       Date:  2021-05-28       Impact factor: 3.738

6.  Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study.

Authors:  Rui Ren; Yu Ma; Fang Deng; Tao Li; Hongyan Wang; Jing Wei; Xiaoyan Jiang; Min He; Mingyuan Tian; Dongfang Liu; Bing Chen; Wuquan Deng
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-22       Impact factor: 3.168

7.  The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults.

Authors:  Jeong Mi Kim; Bo Hyun Kim; Hyungi Lee; Eun Heui Kim; Mijin Kim; Jong Ho Kim; Yun Kyung Jeon; Sang Soo Kim; In Joo Kim; Yong Ki Kim
Journal:  Diabetes Metab J       Date:  2019-04-03       Impact factor: 5.376

8.  Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021).

Authors:  Youshuo Liu; Zhongyan Shan
Journal:  Aging Med (Milton)       Date:  2021-07-02

9.  Reference Intervals for Serum Thyroid-Stimulating Hormone Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis.

Authors:  Xichang Wang; Yongze Li; Xiaodan Zhai; Haoyu Wang; Fan Zhang; Xiaotong Gao; Shengyu Liu; Weiping Teng; Zhongyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

10.  Age- and Sex-Specific TSH Upper-Limit Reference Intervals in the General French Population: There Is a Need to Adjust Our Actual Practices.

Authors:  Véronique Raverot; Maxime Bonjour; Juliette Abeillon du Payrat; Pauline Perrin; Florence Roucher-Boulez; Helene Lasolle; Fabien Subtil; Françoise Borson-Chazot
Journal:  J Clin Med       Date:  2020-03-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.